A considerable proportion of patients with high-grade serous cancer (HGSC) have missed opportunities for risk assessment with genetic testing and for surgical prevention, according to a study published online August 13 in JAMA Surgery.
from Medical Xpress - latest medical and health news stories https://ift.tt/sIJCjYF
